Table 3 Percentage of multi-way probability sensitivity analyses that are cost-effective for a willingness to pay €50,000 per QALY and the lower bound of willingness per QALY in euros for which 50% of the multi-way probability analyses are cost-effective
Cut-off value | 5% of patients treated | 10% of patients treated | 20% of patients treated |
|---|---|---|---|
Willingness to pay €50,000 per additional QALY | |||
 Lifetime benefit based treatment | 69% | 77.2% | 84.1% |
 10-year risk-based treatment | 51.6% | 47.3% | 38.8% |
Lower bound of willingness to pay per additional QALY | |||
 Lifetime benefit based treatment | € 35,900 | € 38,400 | € 41,700 |
 10-year risk-based treatment | € 47,800 | € 51,300 | € 53,100 |